Literature DB >> 8347363

Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Harlem Study Team.

J Mandelblatt1, M Traxler, P Lakin, P Kanetsky, L Thomas, P Chauhan, S Matseoane, E Ramsey.   

Abstract

Our objective is to describe the clinical findings from a nurse-practitioner-based breast and cervical cancer screening program for poor, elderly, black women. We designed a cross-sectional descriptive study set at an urban public hospital medical clinic. All women 65 years of age and older were eligible to be screened. We measured these main outcomes: rates of participation, abnormal tests, and neoplasia. Women were offered screening during a routine visit. Of 689 women, 491 (71%) participated. Mammography was completed by 66% of women; one had stage 1 cancer, and 76% were negative. Among the women (24%) with abnormal mammograms, the overwhelming majority were diagnosed with benign lesions. For ten of 450 women completing Papanicolaou (Pap) smears, results were suspicious or positive for malignancy, for a prevalence rate of 22.2/1,000 (95% confidence interval [CI] = 8.6/1,000 to 35.8/1,000). Three were subsequently designated falsely positive; five had confirmed cervical neoplasia; and two had other reproductive malignancies. Two women with negative smears also had neoplasia: one with vulvar cancer and one with human papilloma virus (HPV) infection and cervical neoplasia, for a total of six cervical neoplasias. Interestingly, one-fifth of women with a hysterectomy had an intact cervix, including one with cervical neoplasia. Nearly one-third of women with abnormal Paps or mammograms failed to complete follow-up. Success of screening programs for the elderly will depend on the risk group targeted, careful examination, degree of sensitivity and specificity of the tests, and acceptability of follow-up diagnosis and treatment.

Entities:  

Mesh:

Year:  1993        PMID: 8347363

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  12 in total

1.  Timeliness of follow-up after abnormal screening mammography.

Authors:  K Kerlikowske
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Knowledge, beliefs, attitudes, and cancer screening among inner-city African-American women.

Authors:  J F Sung; D S Blumenthal; R J Coates; E Alema-Mensah
Journal:  J Natl Med Assoc       Date:  1997-06       Impact factor: 1.798

3.  An examination of differential follow-up rates in breast cancer screening.

Authors:  P A Webber; P Fox; X Zhang; M Pond
Journal:  J Community Health       Date:  1996-04

Review 4.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

5.  An examination of differential follow-up rates in cervical cancer screening.

Authors:  P Fox; P Amsberger; X Zhang
Journal:  J Community Health       Date:  1997-06

Review 6.  Breast cancer prevention and control among the medically underserved.

Authors:  J F Kerner
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Pap smear rates among Haitian immigrant women in eastern Massachusetts.

Authors:  Eric H Green; Karen M Freund; Michael A Posner; Michele M David
Journal:  Public Health Rep       Date:  2005 Mar-Apr       Impact factor: 2.792

8.  Cervical cancer screening in the urgent care setting.

Authors:  H Batal; S Biggerstaff; T Dunn; P S Mehler
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

9.  Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women.

Authors:  Swann A Adams; Emily R Smith; James Hardin; Irene Prabhu-Das; Jeanette Fulton; James R Hebert
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

10.  Community-based breast cancer intervention program for older African American women in beauty salons.

Authors:  D A Forte
Journal:  Public Health Rep       Date:  1995 Mar-Apr       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.